BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21899471)

  • 1. Intravenous thrombolytic therapy for acute ischemic stroke.
    Burberi F; Bruscoli M
    N Engl J Med; 2011 Sep; 365(10):965; author reply 966-7. PubMed ID: 21899471
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous thrombolytic therapy for acute ischemic stroke.
    Wechsler LR
    N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous thrombolytic therapy for acute ischemic stroke.
    Cohen JE; Leker RR
    N Engl J Med; 2011 Sep; 365(10):964-5; author reply 966-7. PubMed ID: 21899472
    [No Abstract]   [Full Text] [Related]  

  • 4. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
    Ibrahim MM; Sebastian J; Hussain M; Al-Hussain F; Uchino K; Molina C; Khan K; Demchuk AM; Alexandrov AV; Saqqur M;
    Cerebrovasc Dis; 2010; 30(5):508-13. PubMed ID: 20861622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy for acute ischemic stroke.
    Perl J; Samples SD
    Tech Vasc Interv Radiol; 2001 Jun; 4(2):115-21. PubMed ID: 11981798
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond clinical guidelines: highly effective intravenous thrombolysis therapy in a 104-year-old patient with severe acute ischemic stroke.
    Hoeren M; Leschka SC; Mader I; Wu K; Weiller C; Harloff A
    J Neurol; 2012 Feb; 259(2):377-8. PubMed ID: 21785845
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator approved for stroke.
    Barber A; Gommans J
    N Z Med J; 2005 May; 118(1214):U1432. PubMed ID: 15886728
    [No Abstract]   [Full Text] [Related]  

  • 10. [Guidelines for intravenous thrombolytic therapy in acute ischemic stroke with special reference to those by the Ad Hoc Committee of the Japan Stroke Society].
    Minematsu K
    No To Shinkei; 2006 Nov; 58(11):915-21. PubMed ID: 17133996
    [No Abstract]   [Full Text] [Related]  

  • 11. Stroke center characteristics which influence the administration of thrombolytic therapy for acute ischemic stroke: a national survey of stroke centers in Taiwan.
    Jeng JS; Tang SC; Deng IC; Tsai LK; Yeh SJ; Yip PK
    J Neurol Sci; 2009 Jun; 281(1-2):24-7. PubMed ID: 19362319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of tissue plasminogen activator to treat acute ischemic stroke.
    Alexandrov AW
    Crit Care Nurse; 2010 Oct; 30(5):77-8. PubMed ID: 20889516
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department.
    ; Brown MD; Burton JH; Nazarian DJ; Promes SB
    Ann Emerg Med; 2015 Sep; 66(3):322-333.e31. PubMed ID: 26304253
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombolysis in acute ischaemic stroke: time for a rethink?
    Alper BS; Malone-Moses M; McLellan JS; Prasad K; Manheimer E
    BMJ; 2015 Mar; 350():h1075. PubMed ID: 25786912
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolytic therapy in patients with acute ischemic stroke.
    Hinchey JA; Benesch C
    Arch Neurol; 2000 Oct; 57(10):1430-6. PubMed ID: 11030794
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous thrombolytic therapy for acute ischemic stroke in Tuzla Canton, Bosnia and Herzegovina.
    Smajlović D; Salihović D; Avdić L; Dostović Z; Ibrahimagić OĆ; Vidović M
    Int J Stroke; 2013 Oct; 8(7):E48. PubMed ID: 24024924
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating the elderly stroke patient: complications, controversies, and best care metrics.
    Heitsch LE; Panagos PD
    Clin Geriatr Med; 2013 Feb; 29(1):231-55. PubMed ID: 23177609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombolytic therapy for acute ischemic stroke].
    Mori E
    Nihon Rinsho; 2006 Nov; 64 Suppl 8():33-7. PubMed ID: 17469531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.